TNF-alpha inhibitor therapy for granuloma annulare

Key Points

• TNF-alpha inhibitor therapy improves symptoms in granuloma annulare, with effective skin lesion reduction.
• Primary treatment involves biologics, including TNF-alpha inhibitors, which target inflammatory responses.
• Current interventions include topical steroids, but biologics offer a potentially more effective alternative.
• Further research is essential to validate the long-term benefits of TNF-alpha inhibitors in granuloma annulare treatment.